Arbro Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.99 Cr
as on 31-08-2024
- Paid Up Capital ₹ 1.78 Cr
as on 31-08-2024
- Company Age 39 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.82 Cr
as on 31-08-2024
- Satisfied Charges ₹ 13.70 Cr
as on 31-08-2024
- Revenue 86.43%
(FY 2023)
- Profit -5.76%
(FY 2023)
- Ebitda -11.91%
(FY 2023)
- Net Worth 5.83%
(FY 2023)
- Total Assets 6.50%
(FY 2023)
About Arbro Pharmaceuticals
The Corporate was formerly known as Arbro Pharmaceuticals Ltd.. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.99 Cr and a paid-up capital of Rs 1.78 Cr.
The company currently has active open charges totaling ₹14.82 Cr. The company has closed loans amounting to ₹13.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijay Arora, Saurabh Arora, and Sunil Jaitly serve as directors at the Company.
- CIN/LLPIN
U24232DL1985PTC021362
- Company No.
021362
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationNa, Delhi
- Telephone
- Email Address
- Website
- Social Media
What products or services does Arbro Pharmaceuticals Private Limited offer?
Arbro Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Cancer Medicines, Evertor Tablet, Common Disease Medicines, Pharmaceutical Tablets, Casodex Tablet, Antiviral Drugs, Inosine Pranobex Tablets, TB, Tumor & Cancer Drugs, Brain & Nervous System Drugs, Psychotherapeutic Agents.
Who are the key members and board of directors at Arbro Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Arora  | Managing Director | 28-Jun-1985 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saurabh Arora | Director | 05-Aug-2005 | Current |
| Sunil Jaitly | Whole-Time Director | 05-Dec-1998 | Current |
Financial Performance of Arbro Pharmaceuticals.
Arbro Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 86.43% increase. The company also saw a slight decrease in profitability, with a 5.76% decrease in profit. The company's net worth moved up by a moderate rise of 5.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arbro Pharmaceuticals?
In 2023, Arbro Pharmaceuticals had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
India Section Of Association Of Official Analytical Chemists InternationalActive 11 years 11 monthsSaurabh Arora is a mutual person
Alcatec Research Laboratories India Private LimitedActive 28 years 9 monthsVijay Arora and Saurabh Arora are mutual person
Auriga Research Private LimitedActive 30 years 29 daysVijay Arora and Saurabh Arora are mutual person
Arbro Formulations Private LimitedActive 2 years 9 monthsVijay Arora and Saurabh Arora are mutual person
- Ningen Skin Sciences Private LimitedActive 2 years 25 days
Vijay Arora and Saurabh Arora are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Mar 2021 | ₹1.79 M | Open |
Hdfc Bank Limited Creation Date: 28 Aug 2020 | ₹0.52 M | Open |
Hdfc Bank Limited Creation Date: 28 Aug 2018 | ₹0.41 M | Open |
How Many Employees Work at Arbro Pharmaceuticals?
Arbro Pharmaceuticals has a workforce of 369 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arbro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arbro Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
